Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
November 15, 2025Journal of Clinical MedicineOpen Access

Treatment of Severe Tricuspid Regurgitation with the TricValve System Implantation—Preliminary Results of a Prospective Registry

View Full Paper
Ask AI
Bookmark
Share

Authors

ARAdam RdzanekMDMaciej DąbrowskiEPEwa Pędzich

Discussion

Loading...

Member takes

Overview

Prospective registry highlights symptom reduction in tricuspid regurgitation patients after TricValve implantation, suggesting benefits despite high mortality risks.

Key Points

  • To summarize early experiences with TricValve system implantation for severe tricuspid regurgitation.
  • Patients referred for tricuspid regurgitation treatment but not eligible for T-TEER were selected for the registry.
  • Heart Team discussions determined eligibility for caval valve implantation.
  • Four patients were included, all highly symptomatic with NYHA class III.
  • At 6-month follow-up, three of four patients showed symptom reduction.
  • Long-term survival was limited, primarily due to heart failure and severe comorbidities.

Cite This Study

Rdzanek et al. (2025) studied this question.

synapsesocial.com/papers/69251994c0ce034ddc353863https://doi.org/10.3390/jcm14228103
View Full Paper
Ask AI
Bookmark
Share